Colgate-Palmolive (NYSE:CL) Stock Position Reduced by Bfsg LLC

Bfsg LLC trimmed its position in Colgate-Palmolive (NYSE:CLFree Report) by 1.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 82,087 shares of the company’s stock after selling 1,002 shares during the period. Colgate-Palmolive makes up approximately 0.9% of Bfsg LLC’s investment portfolio, making the stock its 27th largest position. Bfsg LLC’s holdings in Colgate-Palmolive were worth $7,463,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Creative Planning lifted its holdings in shares of Colgate-Palmolive by 2.0% in the 3rd quarter. Creative Planning now owns 218,018 shares of the company’s stock worth $22,632,000 after purchasing an additional 4,372 shares during the last quarter. Swedbank AB lifted its stake in shares of Colgate-Palmolive by 1.4% in the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after acquiring an additional 40,324 shares during the period. Global Retirement Partners LLC boosted its holdings in shares of Colgate-Palmolive by 16.5% in the third quarter. Global Retirement Partners LLC now owns 7,466 shares of the company’s stock valued at $775,000 after acquiring an additional 1,056 shares in the last quarter. Blue Trust Inc. increased its stake in shares of Colgate-Palmolive by 314.4% during the third quarter. Blue Trust Inc. now owns 5,263 shares of the company’s stock valued at $511,000 after acquiring an additional 3,993 shares during the period. Finally, Capital Investment Advisors LLC raised its holdings in Colgate-Palmolive by 4.3% during the third quarter. Capital Investment Advisors LLC now owns 9,396 shares of the company’s stock worth $975,000 after purchasing an additional 384 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CL has been the subject of a number of research reports. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. UBS Group dropped their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Raymond James restated an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Finally, Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $101.16.

Read Our Latest Stock Report on CL

Colgate-Palmolive Stock Performance

CL stock opened at $86.10 on Tuesday. The stock has a market cap of $70.34 billion, a P/E ratio of 24.46, a P/E/G ratio of 4.12 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The firm has a 50 day simple moving average of $89.53 and a 200 day simple moving average of $96.33. Colgate-Palmolive has a 52 week low of $83.20 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm earned $0.87 EPS. Research analysts anticipate that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.